Related Experiment Video
Updated: Jul 15, 2026

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
Characterization of a novel T4-type Stenotrophomonas maltophilia virulent phage Smp14
Chiy-Rong Chen1, Ching-Hsuan Lin, Juey-Wen Lin
1Institute of Molecular Biology, National Chung Hsing University, Taichung, 402, Taiwan.
Abstract:
Stenotrophomonas maltophilia (Sm), with most of the isolates being resistant to multidrugs, is an opportunistic bacterium causing nosocomial infections. In this study, a novel virulent Sm phage, Smp14, was characterized. Electron microscopy showed that Smp14 resembled members of Myoviridae and adsorbed to poles of the host cells during infection. It lysed 37 of 87 clinical Sm isolates in spot test, displayed a latent period of ca. 20 min, and had a burst size of ca. 150. Its genome (estimated to be 160 kb by PFGE), containing m4C and two unknown modified bases other than m5C and m6A as identified by HPLC, resisted to digestion with many restriction endonucleases except MseI. These properties indicate that it is a novel Sm phage distinct from the previously reported phiSMA5 which has a genome of 250 kb digestible with various restriction enzymes. Sequencing of a 16 kb region revealed 12 ORFs encoding structural proteins sharing 15-45% identities with the homologues from T4-type phages. SDS-PAGE displayed 20 virion proteins, with the most abundant one being the 39 kDa major capsid protein (gp23), which had the N-terminal 52 amino acids removed. Phylogenetic analysis based on gp23 classified Smp14 into a novel single-membered T4-type subgroup.
Insights
A novel virulent Stenotrophomonas maltophilia (Sm) phage, Smp14, was characterized. This phage shows potential for combating multidrug-resistant Sm infections, distinct from previously identified phages.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- Stenotrophomonas maltophilia (Sm) is an opportunistic pathogen causing multidrug-resistant nosocomial infections.
- Bacteriophages offer a potential therapeutic avenue against antibiotic-resistant bacteria.
Purpose of the Study:
- To characterize a novel virulent Stenotrophomonas maltophilia phage, Smp14.
- To assess its potential as a therapeutic agent against Sm.
Main Methods:
- Electron microscopy for morphology and adsorption analysis.
- Spot tests for lytic activity against clinical Sm isolates.
- PFGE and HPLC for genome size and base composition analysis.
- SDS-PAGE and sequence analysis of virion proteins and ORFs.
Main Results:
- Smp14, a Myoviridae-like phage, lysed 37/87 clinical Sm isolates.
- It has a latent period of ~20 min and a burst size of ~150.
- The phage genome is ~160 kb, contains unusual modified bases, and is resistant to most restriction enzymes.
- Phylogenetic analysis places Smp14 in a novel T4-type subgroup.
Conclusions:
- Smp14 is a novel, virulent Stenotrophomonas maltophilia phage with unique genomic and biological properties.
- Its lytic activity against multidrug-resistant clinical isolates suggests therapeutic potential.
- Smp14 represents a distinct lineage within T4-type phages.
Related Concept Videos
DNA Bacteriophages
Viral Replication: Lytic Cycle
Regulation of Bacterial Virulence
Lytic Cycle of Bacteriophages
Bacterial Phylum Tenericutes
Lysogenic Cycle of Bacteriophages

